Finance

Beta
Lists
MBX:NASDAQ
MBX Biosciences Inc
$31.47
-1.35%
(-0.43) 1D
$31.47
0.00% (0.00)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MBX...
Open
$31.83
High
$32.06
Low
$30.80
Mkt. cap
1.50B
Avg. vol.
621.28K
Volume
821.40K
52-wk high
$45.85
52-wk low
$9.43
EPS
-$2.21
Shares outstanding
47.60M
No. of employees
63
Open
$31.83
High
$32.06
Low
$30.80
Mkt. cap
1.50B
Avg. vol.
621.28K
Volume
821.40K
52-wk high
$45.85
52-wk low
$9.43
EPS
-$2.21
Shares outstanding
47.60M
No. of employees
63
News stories
From sources across the web
About MBX Biosciences Inc
CEO-
Employees63
Founded2018
HeadquartersCarmel, Indiana, United States
SectorPharmaceutical industry
Websitembxbio.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.50 / -$0.58
+13.94%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.72M
19.27M
19.46M
18.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08M
4.66M
6.34M
8.79M
Operating expense
21.80M
23.93M
25.80M
27.26M
Total operating expenses
21.80M
23.93M
25.80M
27.26M
Operating income
-21.80M
-23.93M
-25.80M
-27.26M
Other non operating income
-
-
-
-
EBT including unusual items
-19.41M
-21.62M
-22.06M
-23.52M
EBT excluding unusual items
-19.41M
-21.62M
-25.67M
-24.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.41M
-21.62M
-22.06M
-23.52M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.63
-0.49
-0.51
Interest and investment income
2.39M
2.31M
122.00K
3.17M
Interest expense
-
-
-
-
Net interest expenses
2.39M
2.31M
122.00K
3.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.74M
-23.88M
-25.74M
-27.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer